课题基金 / 基金详情

Definition and validity of chronic kidney disease as a cardiovascular risk factor in the community-based population

Definition and validity of chronic kidney disease as a cardiovascular risk factor in the community-based population
慢性肾病作为社区人群心血管危险因素的定义和有效性
批准号:
20590836
负责人:
NAKAMURA Motoyuki
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

NAKAMURA Motoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
尚未确定可有效区分心血管事件(CVE)高风险受试者与日本普通人群的慢性肾脏疾病(CKD)定义。本研究的目的是检查CKD的定义可能有助于预测我们人群中的CVE。基线数据包括血清肌酐和蛋白尿测定社区居住的成年人(n=14131,年龄=63)。采用改良MDRD公式计算肾小球滤过率(eGFR),以eGFR<60、eGFR<60或蛋白尿阳性、eGFR <60或微量蛋白尿3种方法定义CKD。对CVE(卒中、心力衰竭、心肌梗死/猝死)进行了前瞻性调查(平均随访= 2.7年)。结果表明,在CVE风险预测方面,用于区分非CKD的最有力的CKD定义是(3)的定义(HR=1.36,95%CI=1.07-1.74 ; p<0.05)。总之,在日本一般人群中,最有用的CKD定义是eGFR<60和/或尿蛋白微量。
英文摘要
The definition of chronic kidney disease (CKD) which effectively discriminates high-risk subjects for cardiovascular events (CVE) from the Japanese general population has yet to be established. The aim of this study was to examine which definition of CKD might be useful for the prediction of CVE in our population. Baseline data including serum creatinine and proteinuria were determined in community- dwelling adults (n=14131, age=63). Estimated glomerular filtration rate (eGFR) was calculated using a modified MDRD equation, and CKD was defined by the three methods : (1) eGFR<60, (2) eGFR<60 or proteinuria positive, (3) eGFR<60 or proteinuria trace. CVE (stroke, heart failure, myocardial infarction/sudden death) were surveyed prospectively (mean follow-up = 2.7 years). As results, the most powerful definition of CKD for discriminating non-CKD in terms of CVE risk prediction was the definition of (3) (HR=1.36, 95%CI=1.07-1.74 ; p<0.05). In conclusion, the most useful definition of CKD for CVE risk-prediction in the Japanese general population appears to be eGFR<60 and/or urine protein trace.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
危険因子「BNP」
风险因素“BNP”
DOI: --
发表时间: 2011
期刊: 動脈硬化予防 印刷中
影响因子: --
作者: [Abiko A, Makita S, Naganuma Y, Nagai M, Nakamura M, Yasukatsu Izumi, 中村元行]
通讯作者: 中村元行
DOI: --
发表时间: 2010
期刊: Int J Cardiol 143(2)
影响因子: --
作者: [Nakamura M, Tanaka F, Onoda T, Takahashi T, Sakuma M, Kawamura K, Tanno K, Ohsawa M, Itai K, Sakata K, Makita S]
通讯作者: Makita S
Peripheral-BP, Central-BP, and PWV: Which is the Most Useful Predictor for Cardiovascular Events and Death in the General Population
外周血压、中枢血压和 PWV:哪个是一般人群心血管事件和死亡最有用的预测因子
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [小野寺正幸, 中村元行, 他]
通讯作者:
DOI: 10.1016/j.metabol.2009.09.009
发表时间: 2010-05-01
期刊: METABOLISM-CLINICAL AND EXPERIMENTAL
影响因子: 9.8
作者: [Tamada, Makiko, Makita, Shinji, Nakamura, Motoyuki]
通讯作者: Nakamura, Motoyuki
42
    Development of Cardiovascular Risk Scoring System for Japanses Population
    • 批准号:
      23591059
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    Validation of New Identified Cardiovascular Biomarkers in the Japanese General Population
    • 批准号:
      18590786
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.93万
    • 财政年份:
      2006
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    Effects and Mechanisms of Exercise Training on Patients with Chronic Heart Failure due to Valvular Heart Disease
    • 批准号:
      11670706
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      1999
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    Peripheral vascular remodeling in patients with chronic heart failure
    • 批准号:
      09670742
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      1997
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    海外基金